An Exploratory Study of the Safety and Efficacy of a Trigonella foenum-graecum Seed Extract in Early Glucose Dysregulation: A Double-Blind Randomized Placebo-Controlled Trial

Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 14; no. 11; p. 2453
Main Authors Pickering, Emily, Steels, Elizabeth, Rao, Amanda, Steadman, Kathryn J
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 14.11.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum seed extract or matching placebo daily for 12 weeks. Fasting blood glucose (FBG), post-prandial glucose (PPBG), HbA1c, fasting insulin (FI), post-prandial insulin (PPI) and C-peptide were assessed at baseline, week 6 and week 12. Lipid levels, liver enzymes and C-reactive protein (CRP), along with safety markers and tolerability were also assessed at baseline and week 12. Results: By week 12 there was a significant difference in FBG (p < 0.001), PPBG (p = 0.007) and triglycerides (p = 0.030) between treatment groups, with no changes in HbA1c (p = 0.41), FI (p = 0.12), PPI (p = 0.50) or C-peptide (p = 0.80). There was no difference in total cholesterol (p = 0.99), high-density lipoprotein (p = 0.35), low density lipoprotein (p = 0.60) or CRP (p = 0.79). There was no change in safety markers and the treatment was well tolerated. Conclusions: The results of the study indicated that T. foenum-graecum seed extract may influence blood glucose metabolism and larger studies are warranted to evaluate efficacy and potential mechanisms of action.
AbstractList Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum seed extract or matching placebo daily for 12 weeks. Fasting blood glucose (FBG), post-prandial glucose (PPBG), HbA1c, fasting insulin (FI), post-prandial insulin (PPI) and C-peptide were assessed at baseline, week 6 and week 12. Lipid levels, liver enzymes and C-reactive protein (CRP), along with safety markers and tolerability were also assessed at baseline and week 12. Results: By week 12 there was a significant difference in FBG (p < 0.001), PPBG (p = 0.007) and triglycerides (p = 0.030) between treatment groups, with no changes in HbA1c (p = 0.41), FI (p = 0.12), PPI (p = 0.50) or C-peptide (p = 0.80). There was no difference in total cholesterol (p = 0.99), high-density lipoprotein (p = 0.35), low density lipoprotein (p = 0.60) or CRP (p = 0.79). There was no change in safety markers and the treatment was well tolerated. Conclusions: The results of the study indicated that T. foenum-graecum seed extract may influence blood glucose metabolism and larger studies are warranted to evaluate efficacy and potential mechanisms of action.
Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum seed extract or matching placebo daily for 12 weeks. Fasting blood glucose (FBG), post-prandial glucose (PPBG), HbA1c, fasting insulin (FI), post-prandial insulin (PPI) and C-peptide were assessed at baseline, week 6 and week 12. Lipid levels, liver enzymes and C-reactive protein (CRP), along with safety markers and tolerability were also assessed at baseline and week 12. Results: By week 12 there was a significant difference in FBG ( p < 0.001), PPBG ( p = 0.007) and triglycerides ( p = 0.030) between treatment groups, with no changes in HbA1c ( p = 0.41), FI ( p = 0.12), PPI ( p = 0.50) or C-peptide ( p = 0.80). There was no difference in total cholesterol ( p = 0.99), high-density lipoprotein ( p = 0.35), low density lipoprotein ( p = 0.60) or CRP ( p = 0.79). There was no change in safety markers and the treatment was well tolerated. Conclusions: The results of the study indicated that T. foenum-graecum seed extract may influence blood glucose metabolism and larger studies are warranted to evaluate efficacy and potential mechanisms of action.
Author Pickering, Emily
Steels, Elizabeth
Steadman, Kathryn J
Rao, Amanda
AuthorAffiliation 2 Evidence Sciences Pty, Ltd., Brisbane, QLD 4005, Australia
1 School of Pharmacy, University of Queensland, Brisbane, QLD 4102, Australia
3 School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD 4102, Australia
AuthorAffiliation_xml – name: 1 School of Pharmacy, University of Queensland, Brisbane, QLD 4102, Australia
– name: 2 Evidence Sciences Pty, Ltd., Brisbane, QLD 4005, Australia
– name: 3 School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD 4102, Australia
Author_xml – sequence: 1
  givenname: Emily
  orcidid: 0000-0002-7730-8164
  surname: Pickering
  fullname: Pickering, Emily
  organization: Evidence Sciences Pty, Ltd., Brisbane, QLD 4005, Australia
– sequence: 2
  givenname: Elizabeth
  surname: Steels
  fullname: Steels, Elizabeth
  organization: Evidence Sciences Pty, Ltd., Brisbane, QLD 4005, Australia
– sequence: 3
  givenname: Amanda
  orcidid: 0000-0003-0090-9217
  surname: Rao
  fullname: Rao, Amanda
  organization: School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD 4102, Australia
– sequence: 4
  givenname: Kathryn J
  orcidid: 0000-0001-7357-330X
  surname: Steadman
  fullname: Steadman, Kathryn J
  organization: School of Pharmacy, University of Queensland, Brisbane, QLD 4102, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36432644$$D View this record in MEDLINE/PubMed
BookMark eNptUk1v1DAQjVARLaU_AWSJC5eAvxLHHJCW7VIqVQKx5WxNHDublRMvjoMafhS_EW-3VC3CF1szb968eZ7n2dHgB5NlLwl-y5jE73YbCD1oM8VOj4QTQnnBnmQnREqZc0nZ0YP3cXY2jlucDmOkYvJZdsxKzmjJ-Un2ezGg1c3O-QDRhxmt49TMyFsUNwatwZo4IxgatLK206BvU4CuQ9cmRc4Bst4MU5-3AYyeerQ2JoFvYgAdUZe4IbgZXbhJ-9Gg83kMpp0cxM4P79ECnfupdib_6LrU41tq5PvuV2L46tJ0tc-XfojBO5dCqSe4F9lTC240Z3f3afb90-p6-Tm_-nJxuVxc5brARcwLIaGqLW40hbrQtNFEMOBGCqELXkuKaVlDXVdMN1rakuiCEExpSTnDtCrZaXZ54G08bNUudD2EWXno1G3Ah1ZBSOY7ozQjwpa04EQAF5RCBaIAI4hJFlfcJq4PB67dVPem0SaNBO4R6ePM0G1U638qWcqKCpwI3twRBP9jMmNUfTfqvfuD8dOoqOB4rx-TBH39D3TrpzAkq_aoigmWhCZUcUDp4Mf0I_ZeDMFqv2DqvwuW6l49nOS-6u86sT9ff9N1
CitedBy_id crossref_primary_10_1002_fsn3_3959
crossref_primary_10_1016_j_jaim_2023_100806
crossref_primary_10_2174_2210315513666230309105835
crossref_primary_10_3390_ijms25136987
crossref_primary_10_3390_ijms241813999
Cites_doi 10.1016/B978-0-12-821038-3.00037-9
10.3892/mmr.2015.4298
10.1016/j.ctim.2020.102315
10.1155/2019/8507453
10.1371/journal.pone.0106039
10.1089/jmf.2008.0199
10.4103/ayu.AYU_209_15
10.4239/wjd.v6.i12.1207
10.1007/s11010-014-2152-x
10.1111/j.1601-5215.2007.00217.x
10.1007/s11655-007-9005-3
10.3390/biom9100551
10.1002/jsfa.7057
10.2174/1573401317666210706121806
10.1136/bmj.m2297
10.4314/ahs.v19i1.34
10.1016/j.ctim.2022.102852
10.1016/j.diabres.2019.03.038
10.1186/s40200-015-0208-4
10.1155/2016/7493694
10.1007/s00394-015-1037-4
10.3109/13880209.2013.826247
10.1024/0300-9831.79.1.34
10.1024/0300-9831/a000206
10.1038/ejcn.2016.148
10.3402/fnr.v60.32382
10.1016/j.jep.2016.08.003
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID NPM
AAYXX
CITATION
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/pharmaceutics14112453
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
ProQuest Central Student
Research Library Prep
Research Library
Research Library (Corporate)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


CrossRef
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: COVID
  name: Coronavirus Research Database
  url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/coronavirus
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1999-4923
ExternalDocumentID oai_doaj_org_article_c317f625417a4722a8a75ae71e32684f
10_3390_pharmaceutics14112453
36432644
Genre Journal Article
GeographicLocations Hong Kong China
Australia
Lantau Island
GeographicLocations_xml – name: Lantau Island
– name: Hong Kong China
– name: Australia
GrantInformation_xml – fundername: Gencor Pacific Ltd, Hong Kong
– fundername: Gencor Pacific Ltd., Hong Kong
– fundername: University of Queensland Graduate School
GroupedDBID ---
3V.
53G
5VS
8G5
AADQD
ABDBF
ABUWG
ACGFO
ACIHN
AEAQA
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BENPR
BPHCQ
CCPQU
DIK
DWQXO
EBD
ESX
F5P
FD6
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MK0
MODMG
M~E
NPM
OK1
P6G
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TR2
TUS
AAYXX
CITATION
7XB
8FK
COVID
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c505t-579a8bf0dc2ab5c2dc173a4e977c54b92026babb83cdc9f61c511022624302863
IEDL.DBID RPM
ISSN 1999-4923
IngestDate Tue Oct 22 14:49:23 EDT 2024
Tue Sep 17 21:31:46 EDT 2024
Wed Dec 04 02:08:19 EST 2024
Mon Nov 18 17:51:01 EST 2024
Fri Dec 06 08:42:22 EST 2024
Sat Sep 28 08:19:17 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords post-prandial glucose
Trigonella foenum-graecum
fasting blood glucose
type 2 diabetes
insulin
prediabetes
fenugreek
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c505t-579a8bf0dc2ab5c2dc173a4e977c54b92026babb83cdc9f61c511022624302863
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7730-8164
0000-0003-0090-9217
0000-0001-7357-330X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698270/
PMID 36432644
PQID 2748373254
PQPubID 2032349
ParticipantIDs doaj_primary_oai_doaj_org_article_c317f625417a4722a8a75ae71e32684f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9698270
proquest_miscellaneous_2740511001
proquest_journals_2748373254
crossref_primary_10_3390_pharmaceutics14112453
pubmed_primary_36432644
PublicationCentury 2000
PublicationDate 20221114
PublicationDateYYYYMMDD 2022-11-14
PublicationDate_xml – month: 11
  year: 2022
  text: 20221114
  day: 14
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Pharmaceutics
PublicationTitleAlternate Pharmaceutics
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Verma (ref_20) 2016; 60
Fang (ref_34) 2016; 2016
Elsaadany (ref_35) 2022; 18
Geberemeskel (ref_27) 2019; 2019
ref_33
Rafraf (ref_11) 2014; 84
Yadav (ref_7) 2014; 52
Kassaian (ref_8) 2009; 79
Najdi (ref_15) 2019; 19
Losso (ref_9) 2009; 12
Verma (ref_16) 2015; 4
Kanat (ref_3) 2015; 6
Tharaheswari (ref_29) 2014; 396
Chakarova (ref_26) 2019; 151
Bhaktha (ref_10) 2011; 2
Gong (ref_18) 2016; 194
ref_23
ref_22
Cai (ref_2) 2020; 370
Gao (ref_30) 2015; 12
Ranade (ref_12) 2017; 38
Broca (ref_31) 1999; 277
ref_1
Gupta (ref_13) 2001; 49
Vuksan (ref_5) 2017; 71
Ng (ref_21) 2007; 19
(ref_25) 2022; 70
ref_28
Karim (ref_24) 2009; 62
Robert (ref_6) 2016; 55
Naidu (ref_32) 2015; 95
Lu (ref_14) 2008; 14
Hadi (ref_19) 2020; 49
ref_4
Gaddam (ref_17) 2015; 14
References_xml – volume: 62
  start-page: 315
  year: 2009
  ident: ref_24
  article-title: Antidiabetic effects of exercise and fenugreek supplementation in males with NIDDM
  publication-title: Med. Dello Sport
  contributor:
    fullname: Karim
– ident: ref_28
  doi: 10.1016/B978-0-12-821038-3.00037-9
– volume: 12
  start-page: 6555
  year: 2015
  ident: ref_30
  article-title: 4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-alpha and regulating the expression of insulin signal transduction proteins
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2015.4298
  contributor:
    fullname: Gao
– volume: 49
  start-page: 102315
  year: 2020
  ident: ref_19
  article-title: The effect of fenugreek seed supplementation on serum irisin levels, blood pressure, and liver and kidney function in patients with type 2 diabetes mellitus: A parallel randomized clinical trial
  publication-title: Complement. Ther. Med.
  doi: 10.1016/j.ctim.2020.102315
  contributor:
    fullname: Hadi
– volume: 2019
  start-page: 8507453
  year: 2019
  ident: ref_27
  article-title: Antidiabetic effect of fenugreek seed powder solution (Trigonella foenum-graecum L.) on hyperlipidemia in diabetic patients
  publication-title: J. Diabetes Res.
  doi: 10.1155/2019/8507453
  contributor:
    fullname: Geberemeskel
– ident: ref_33
  doi: 10.1371/journal.pone.0106039
– volume: 277
  start-page: E617
  year: 1999
  ident: ref_31
  article-title: 4-Hydroxyisoleucine: Experimental evidence of its insulinotropic and antidiabetic properties
  publication-title: Am. J. Physiol.
  contributor:
    fullname: Broca
– volume: 12
  start-page: 1046
  year: 2009
  ident: ref_9
  article-title: Fenugreek bread: A treatment for diabetes mellitus
  publication-title: J. Med. Food
  doi: 10.1089/jmf.2008.0199
  contributor:
    fullname: Losso
– volume: 49
  start-page: 1057
  year: 2001
  ident: ref_13
  article-title: Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: A double blind placebo controlled study
  publication-title: J. Assoc. Physicians India
  contributor:
    fullname: Gupta
– volume: 38
  start-page: 24
  year: 2017
  ident: ref_12
  article-title: A simple dietary addition of fenugreek seed leads to the reduction in blood glucose levels: A parallel group, randomized single-blind trial
  publication-title: Ayu
  doi: 10.4103/ayu.AYU_209_15
  contributor:
    fullname: Ranade
– volume: 6
  start-page: 1207
  year: 2015
  ident: ref_3
  article-title: Treatment of prediabetes
  publication-title: World J. Diabetes
  doi: 10.4239/wjd.v6.i12.1207
  contributor:
    fullname: Kanat
– volume: 396
  start-page: 161
  year: 2014
  ident: ref_29
  article-title: Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats
  publication-title: Mol. Cell Biochem.
  doi: 10.1007/s11010-014-2152-x
  contributor:
    fullname: Tharaheswari
– ident: ref_1
– volume: 19
  start-page: 304
  year: 2007
  ident: ref_21
  article-title: The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure
  publication-title: Acta Neuropsychiatr.
  doi: 10.1111/j.1601-5215.2007.00217.x
  contributor:
    fullname: Ng
– volume: 14
  start-page: 56
  year: 2008
  ident: ref_14
  article-title: Clinical observation on Trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus
  publication-title: Chin. J. Integr. Med.
  doi: 10.1007/s11655-007-9005-3
  contributor:
    fullname: Lu
– ident: ref_23
– ident: ref_4
  doi: 10.3390/biom9100551
– volume: 95
  start-page: 3177
  year: 2015
  ident: ref_32
  article-title: Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet–streptozotocin-induced diabetic rats
  publication-title: J. Sci. Food Agri.
  doi: 10.1002/jsfa.7057
  contributor:
    fullname: Naidu
– volume: 18
  start-page: 231
  year: 2022
  ident: ref_35
  article-title: Antihyperglycemic effect of fenugreek and ginger in patients with type 2 diabetes: A double-blind, placebo-controlled study
  publication-title: Curr. Nutr. Food Sci.
  doi: 10.2174/1573401317666210706121806
  contributor:
    fullname: Elsaadany
– volume: 370
  start-page: m2297
  year: 2020
  ident: ref_2
  article-title: Association between prediabetes and risk of all cause mortality and cardiovascular disease: Updated meta-analysis
  publication-title: BMJ
  doi: 10.1136/bmj.m2297
  contributor:
    fullname: Cai
– volume: 19
  start-page: 1594
  year: 2019
  ident: ref_15
  article-title: A randomized controlled clinical trial evaluating the effect of Trigonella foenum-graecum (fenugreek) versus glibenclamide in patients with diabetes
  publication-title: Afr. Health Sci.
  doi: 10.4314/ahs.v19i1.34
  contributor:
    fullname: Najdi
– volume: 70
  start-page: 102852
  year: 2022
  ident: ref_25
  article-title: Effect of flaxseed (Linum usitatissimum) supplementation on glycemic control and insulin resistance in prediabetes and type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
  publication-title: Complement. Ther. Med.
  doi: 10.1016/j.ctim.2022.102852
– volume: 151
  start-page: 56
  year: 2019
  ident: ref_26
  article-title: Assessment of glucose variability in subjects with prediabetes
  publication-title: Diabetes Res. Clin. Pract.
  doi: 10.1016/j.diabres.2019.03.038
  contributor:
    fullname: Chakarova
– volume: 14
  start-page: 74
  year: 2015
  ident: ref_17
  article-title: Role of fenugreek in the prevention of type 2 diabetes mellitus in prediabetes
  publication-title: J. Diabetes Metab. Disord.
  doi: 10.1186/s40200-015-0208-4
  contributor:
    fullname: Gaddam
– volume: 2016
  start-page: 7493694
  year: 2016
  ident: ref_34
  article-title: Diosgenin and 5-methoxypsoralen ameliorate insulin resistance through ER-α/PI3K/Akt-signaling pathways in HepG2 cells
  publication-title: Evid-Based Comp. Alt. Med.
  doi: 10.1155/2016/7493694
  contributor:
    fullname: Fang
– volume: 55
  start-page: 2275
  year: 2016
  ident: ref_6
  article-title: Reduction of postprandial blood glucose in healthy subjects by buns and flatbreads incorporated with fenugreek seed powder
  publication-title: Eur. J. Nutr.
  doi: 10.1007/s00394-015-1037-4
  contributor:
    fullname: Robert
– volume: 52
  start-page: 243
  year: 2014
  ident: ref_7
  article-title: Pharmacological effects of Trigonella foenum-graecum L. in health and disease
  publication-title: Pharm. Biol.
  doi: 10.3109/13880209.2013.826247
  contributor:
    fullname: Yadav
– volume: 79
  start-page: 34
  year: 2009
  ident: ref_8
  article-title: Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients
  publication-title: Int. J. Vitam. Nutr. Res.
  doi: 10.1024/0300-9831.79.1.34
  contributor:
    fullname: Kassaian
– volume: 84
  start-page: 196
  year: 2014
  ident: ref_11
  article-title: Effect of fenugreek seeds on serum metabolic factors and adiponectin levels in type 2 diabetic patients
  publication-title: Int. J. Vitam. Nutr. Res.
  doi: 10.1024/0300-9831/a000206
  contributor:
    fullname: Rafraf
– volume: 71
  start-page: 234
  year: 2017
  ident: ref_5
  article-title: Comparison of flax (Linum usitatissimum) and Salba-chia (Salvia hispanica L.) seeds on postprandial glycemia and satiety in healthy individuals: A randomized, controlled, crossover study
  publication-title: Eur. J. Clin. Nutr.
  doi: 10.1038/ejcn.2016.148
  contributor:
    fullname: Vuksan
– volume: 60
  start-page: 32382
  year: 2016
  ident: ref_20
  article-title: A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro) in patients with type 2 diabetes
  publication-title: Food Nutr. Res.
  doi: 10.3402/fnr.v60.32382
  contributor:
    fullname: Verma
– volume: 194
  start-page: 260
  year: 2016
  ident: ref_18
  article-title: Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: A meta-analysis
  publication-title: J. Ethnopharmacol.
  doi: 10.1016/j.jep.2016.08.003
  contributor:
    fullname: Gong
– ident: ref_22
– volume: 2
  start-page: 1231
  year: 2011
  ident: ref_10
  article-title: Management of newly diagnosed diabetes by Trigonella foenum-graecum
  publication-title: Int. J. Res. Ayu. Pharm.
  contributor:
    fullname: Bhaktha
– volume: 4
  start-page: 2266
  year: 2015
  ident: ref_16
  article-title: Clinical evaluation fenugreek seed extract in patients with type-2 diabetes: An add-on study in 154 patients
  publication-title: World J. Pharm. Res.
  contributor:
    fullname: Verma
SSID ssj0000331839
Score 2.3444908
Snippet Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy...
Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2453
SubjectTerms Cardiovascular disease
Clinical trials
Diabetes
Double-blind studies
fasting blood glucose
fenugreek
Glucose
Herbal medicine
Insulin resistance
Metabolism
post-prandial glucose
prediabetes
Seeds
Trigonella foenum-graecum
type 2 diabetes
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqTr1UfXcLraZSxQmXJHYe7m2hUFSp1aosErfIT1gJEsRmD-FH8Rs7k4R9VEi99Gonjp0Z298k33xm7LNHCGqTYHiRqZxLGxtuvIy5EJmLXKEzYylR-Oev7ORM_jhPz9eO-iJOWC8P3L-4fYsbXECQLuNck7ChLnSeap_HXpBQSehW3yhZC6a6NViQr6o-ZUdgXL9_c7n6RDyPJcIMmYqNzajT7H8MaP7Nl1zbgI6fs2cDcoRx3-MX7ImvXrLdSf_Adg-mq0yq-R7swmQlSt2-YvfjCnq-XfdbHYg_2EIdAAEgnOrgmxZ05eCIJCWwParSMMXYvSYijIZQE2meX9xqbxfXcIq7HjbYUJIVzLBtEkqG7z0BHr61ONiL4WSwrzAGxOnmyvMDBLUOfuOD6uvZHbYwoa_4puaHPWP-CoumNCVes7Pjo-nhCR_OauAWMVTD01zpwoTI2UQbtL6zcS609AgvbSqNSjDWM9qYQlhnVchii0gP8UOWSIEQJxNv2FaFA3rHQGWecFwUXCikck5pEuVCnFSoNCR5PGJfHoxW3vSSHCWGMmTl8lErj9gBmXZ5MSlqdwXoZ-XgZ-W__GzEdh4coxym-bzEkB4DfIF3jdinZTVOUPrroitfL7prIhprhB1_2_vRsicC8SAh0hHLNzxso6ubNdXsshMBV5kqkjx6_z_Gts2eJpTVQexGucO2mtuF_4BYqzEfu2n1B7NfKwU
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Coronavirus Research Database
  dbid: COVID
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5Be-HC-xEoaJFQT93U9q4fywWlaUtBAiKaot6sfaYRrR0S55D-KH4jM7aTkKriwNVrbWaiz7Pf7M58S8g7BxTURF6zLJEpEybUTDsRMs4TG9hMJdpgo_CXr8nJmfh8Hp-3G26ztqxyGRPrQG1Lg3vk-5A9QS7FIZ_5MPnF8NYoPF1tr9C4S7Y5UAdA-Hb_249Ph6tdloAjZmXTusMhv9-fXKy3imehALohYr6xKNXa_bcRzpt1k38tRMcPSL50oak_-dmdV7prrm-oO_6_jw_J_Zaj0l4Dqkfkjisek91B49Jijw7XPVuzPbpLB2v568UT8rtX0Kayrz7Ap1ipuKClp0A16anyrlpQVVh6hOIVMB8OKToEM0osuVHUl1iez0ZT5cz8ip7C-goTVtjORccwN0oy049NqT09XMDfOWrvIHtPexQyAn3p2AHQZ0u_ww-VV-NrmGGA5wW6ZP2mNv8SHg3x43tKzo6Phv0T1t4KwQywtYrFqVSZ9oE1kdKAM2vClCvhgMiaWGgZQVapldYZN9ZIn4QGOCUwlSQSHMhUwp-RrQIcekGoTBwyxsBbnwlprVQo_wWMLJOxj9KwQ7pLWOSTRvwjh6QJcZTfiqMOOUDwrF5G7e76QTkd5W0oyA1QNg9ppwhThVKdKlNprFwaOo7SO75DdpboyNuAMsvX0OiQt6thCAV4vqMKV87rdwL0NQDDnzdIXVnCgXki9-2QdAPDG6ZujhTji1puXCYyi9Lg5b_NekXuRdgZghWSYodsVdO5ew18rdJv2o_yD4O1R-U
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEF6VcuGCKE9DQYOEeqqL7fVrkRBKS0uFVBTRROrN2mcaKbVLHlLNj-I3MmM7CUHhwNVrj3c9M95vdme-ZeydRQiqI6f8PBWZH-tQ-crGoc95agKTy1RpKhS--JaeD-OvV8nVDlsSKnQfcLY1tKPzpIbTydHdj_oTOvxHijgxZH9_e71e_Z2FMSKIOOH32P0IJ0fK8rroEH_zc-ZkxKLZaxZ0vlrE27qef0vamLEaYv9taPTvpMo_ZqmzR-xhBy-h19rDHtux5WN20G9fWB_CYF1uNTuEA-ivmavrJ-xXr4Q2Ka_ZewdKMqyhcoAoES6ls_MaZGnglHgnUB41SRhggF9RtowEV1FmvT-aSqsXN3CJUyMKnFMlFoxRNrEpw5c2Sx4-1zjYUXd82AfoAYJ5NbH-MSJfA9_xRdXN-CdK6NNSv6r8kzatfoKXBuQ3T9nw7HRwcu53Bzr4GoHW3E8yIXPlAqMjqdBEjA4zLmOLGFQnsRIRBoRKKpVzbbRwaagRDiLISFGTiINS_oztljigFwxEagnsBc64PBbGCEnMXQimcpG4KAs9drRUWnHb8nYUGO-QloutWvbYMal2dTPRbjcXqumo6Ly40Ii2HEaMcZhJYtmUucwSabPQcmLNcR7bXxpGsTTlAuP-nGccn_LY21UzejFtzcjSVovmnoDGGmDHn7d2tOoJR9BIsNVj2YaFbXR1s6UcXzdM4SIVeZQFL__3Y7xiDyIq86B0x3if7c6nC_sawddcvWnc6Tf3uDJQ
  priority: 102
  providerName: Scholars Portal
Title An Exploratory Study of the Safety and Efficacy of a Trigonella foenum-graecum Seed Extract in Early Glucose Dysregulation: A Double-Blind Randomized Placebo-Controlled Trial
URI https://www.ncbi.nlm.nih.gov/pubmed/36432644
https://www.proquest.com/docview/2748373254
https://search.proquest.com/docview/2740511001
https://pubmed.ncbi.nlm.nih.gov/PMC9698270
https://doaj.org/article/c317f625417a4722a8a75ae71e32684f
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWS9NJL0XRVmhosUOQU2ZJILezNdpymBZwaiVPkJpAU6RiwJcPLwfmofmNnJNmOi5x6sQBRokjMjPmGevNEyFcDEFQHVrlJJGKXa1-5ynDfZSzKvCyRkdJYKNy_jq7u-M_78P6AhJtamJK0r9W4mU-mzXz8UHIrZ1Pd2vDEWoN-V0QiCWKvdUgOYfl9kqKXf78M3VRU1ToMUvrW7GG3O7zwOSAMHrK9daiU638OY_5LlXyy9ly-Jq9q0Ejb1eCOyYHJ35CzQfXA9Tkd7oqoFuf0jA52etTrt-RPO6cV1a58o06ROrimhaWA_eittGa5pjLPaA_VJKA_bJJ0CGl7gRwYSW2BfHl3NJdGr6b0FhY86HCJ9VV0DH2jRjL9XnHf6cUaJjuqPwr2jbYpQHQ1MW4H8GxGb-BBxXT8CD0McANfFW63IstP4NQQo-EdubvsDbtXbv2ZBlcDfFq6YSxkoqyX6UAqMHym_ZhJbgBZ6pArEUCap6RSCdOZFjbyNYA8gA5RwBmgm4i9J0c5TOgjoSIyCOE8m9mEiywTEvW4ACIlIrRB7DukuTFaOqvUOFLIYtDK6bNWdkgHTbu9GMW0yxPFfJTWLpVqwFAW8kDuxxK1M2Ui41Ca2DcMtXCsQ043jpHWEb5IIZuH3J7BXQ75sm2G2MQXLjI3xaq8xsO5ejDwD5UfbUfCAAoiGHVIvOdhe0Pdb4FwKPW_a_c_-e87P5GXAVZxIJuRn5Kj5XxlPgO2WqoGedHpXQ9u4Nj99fvHRaPco4DfPk8aZZz9BdgkL-o
link.rule.ids 230,314,727,780,784,864,885,2102,2221,21388,24318,27924,27925,33744,33745,38516,43805,43895,53791,53793,74302,74412
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lc9MwENZAeoAL74ehgJhheqpS25JfXJg0bUmhLRmaMr15JFlKM7R2SJxD-qP4jezaTkI6HQ5cLY-yynxefSvtfkvIBwMUVPtWsThMIia0p5gywmOch5mbxTJUGguFj0_C3pn4ch6cNwdu0yatcuETK0edFRrPyHcgeoJYikM882n8i2HXKLxdbVpo3CUb2MU7aJGN7rcfh3vLUxaXI2aTunSHQ3y_M75YHRVPPQF0QwR8bVOqtPtvI5w38yb_2ogOHpJ0sYQ6_-Rne1aqtr6-oe74_2t8RB40HJV2alA9JndM_oRs9eslzbfpYFWzNd2mW7S_kr-ePyW_OzmtM_uqC3yKmYpzWlgKVJOeSmvKOZV5RvdRvALmwyFJB2BGgSk3ktoC0_PZcCKNnl3RU9hfYcISy7noCOZGSWb6uU61p3tz-DuHTQ-yj7RDISJQl4btAn3O6Hf4oeJqdA0z9PG-QBWsW-fmX8KjAX58z8jZwf6g22NNVwimga2VLIgSGSvrZtqXCnCWaS_iUhggsjoQKvEhqlRSqZjrTCc29DRwSmAqoS84kKmQPyetHBb0ktAkNMgYXZvZWCRZlkiU_wJGBlCyfuQ5pL2ARTquxT9SCJoQR-mtOHLILoJn-TJqd1cPiskwbVxBqoGyWQg7hRdJlOqUsYwCaSLPcJTesQ7ZXKAjbRzKNF1BwyHvl8PgCvB-R-ammFXvuLhWFwx_USN1aQkH5onc1yHRGobXTF0fyUcXldx4EiaxH7mv_m3WO3KvNzg-So8OT76-Jvd9rBLBbEmxSVrlZGbeAHcr1dvmA_0DGDJK1Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLagkxAvaNzLBhgJ7WmmSZybeUHt1jJuVbV10t4iX7tKW1J6eQg_it_IOUnaUjTxGke-5JwTf8f-_JmQ9xYgqA6cYmksEhZqXzFlQ59xHhvPpDJWGg8K_xjGZ5fh16voquE_LRpa5fqfWP2oTaFxjbwD2RPkUhzymY5raBGj08Gn2U-GN0jhTmtzncZ9sgezohe0yF6vPxydb1ZcPI7-K-pjPBxy_c7sertsvPBDgB5hxHcmqErH_y7w-S-H8q9JabBPHjVoknZr8z8m92z-hByN6gbLYzrenq5aHNMjOtoKVZdPye9uTmsOXrXVTpFTWNLCUQCF9EI6uyypzA3to8wE1IdFko7hQxRIjpHUFUikZ5O5tHp1Sy9gJoQKl3jwik6hbhRPpp9rUjw9LWGwk-a2sI-0SwG7qxvLegB0DT2Hhorb6S-oYYQr-6pgJzWL_gYejTFMnpHLQX98csaa-xuYBly1ZFEiZKqcZ3QgFXiE0X7CZWgBcuooVCKA_E9JpVKujRYu9jWgP8AUcYD2S2P-nLRyGNBLQkVsEdt5zrg0FMYIiUJdgJ1SEbkg8dvkw9po2ayW6cggvUErZ3dauU16aNrNy6iyXT0o5pOsCdpMA7hykCCGfiJRVFOmMomkTXzLUSTHtcnh2jGyJvQX2dZR2-TdphiCFndiZG6LVfWOh2P1oOMvaj_a9IQDRkSU2ibJjoftdHW3JJ9eV8LgIhZpkHiv_t-tt-QBRE72_cvw2wF5GOBxDqQ1hoektZyv7GsAWUv1pomePzcsLBQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Exploratory+Study+of+the+Safety+and+Efficacy+of+a+Trigonella+foenum-graecum+Seed+Extract+in+Early+Glucose+Dysregulation%3A+A+Double-Blind+Randomized+Placebo-Controlled+Trial&rft.jtitle=Pharmaceutics&rft.au=Pickering%2C+Emily&rft.au=Steels%2C+Elizabeth&rft.au=Rao%2C+Amanda&rft.au=Steadman%2C+Kathryn+J.&rft.date=2022-11-14&rft.issn=1999-4923&rft.eissn=1999-4923&rft.volume=14&rft.issue=11&rft.spage=2453&rft_id=info:doi/10.3390%2Fpharmaceutics14112453&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_pharmaceutics14112453
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4923&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4923&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4923&client=summon